α3β1 integrin
Recently Published Documents


TOTAL DOCUMENTS

104
(FIVE YEARS 3)

H-INDEX

38
(FIVE YEARS 0)

2021 ◽  
Author(s):  
Sonja Thölmann ◽  
Jochen Seebach ◽  
Tetsuhisa Otani ◽  
Luise Florin ◽  
Hans Schnittler ◽  
...  

Abstract Junctional adhesion molecule (JAM)-A is a cell adhesion receptor localized at epithelial cellcell contacts with enrichment at the tight junctions. Its role during cell-cell contact formation and epithelial barrier formation has intensively been studied. In contrast, its role during collective cell migration is largely unexplored. Here we show that JAM-A regulates collective cell migration of polarized epithelial cells. Depletion of JAM-A in MDCK cells enhances the motility of singly migrating cells but reduces cell motility of cells embedded in a collective by impairing the dynamics of cryptic lamellipodia formation. This activity of JAM-A is observed in cells grown on laminin and collagen I but not on fibronectin or vitronectin. Accordingly, we find that JAM-A exists in a complex with the laminin- and collagen I-binding α3β1 integrin. We also find that JAM-A interacts with CD151, a tetraspanin that forms a stoichiometric complex with α3β1 integrin and that regulates α3β1 integrin activity in different contexts. Mapping experiments indicate that JAM-A associates with both α3β1 integrin and CD151 through its extracellular domain. Similar to depletion of JAM-A, depletion of either α3β1 integrin or CD151 in MDCK cells slows down collective cell migration. Our findings suggest that JAM-A, α3β1 integrin and CD151 exist as a functional complex to regulate collective cell migration of epithelial cells.


2021 ◽  
Vol 58 (4) ◽  
Author(s):  
Venkateswara Gogineni ◽  
Arun  Nalla ◽  
Reshu Gupta ◽  
Meena Gujrati ◽  
Jeffrey Klopfenstein ◽  
...  

2021 ◽  
Vol 22 (1) ◽  
pp. 455
Author(s):  
Kayla Bastian ◽  
Emma Scott ◽  
David J. Elliott ◽  
Jennifer Munkley

Aberrant glycosylation is a universal feature of cancer cells that can impact all steps in tumour progression from malignant transformation to metastasis and immune evasion. One key change in tumour glycosylation is altered core fucosylation. Core fucosylation is driven by fucosyltransferase 8 (FUT8), which catalyses the addition of α1,6-fucose to the innermost GlcNAc residue of N-glycans. FUT8 is frequently upregulated in cancer, and plays a critical role in immune evasion, antibody-dependent cellular cytotoxicity (ADCC), and the regulation of TGF-β, EGF, α3β1 integrin and E-Cadherin. Here, we summarise the role of FUT8 in various cancers (including lung, liver, colorectal, ovarian, prostate, breast, melanoma, thyroid, and pancreatic), discuss the potential mechanisms involved, and outline opportunities to exploit FUT8 as a critical factor in cancer therapeutics in the future.


2020 ◽  
Vol 140 (7) ◽  
pp. B12
Author(s):  
K.J. Bommareddy ◽  
A. Dabaghian ◽  
A. Ndoye ◽  
L. Davis ◽  
C. DiPersio

2020 ◽  
Vol 12 (13) ◽  
pp. 14905-14913 ◽  
Author(s):  
Yan Zou ◽  
Yinping Sun ◽  
Beibei Guo ◽  
Yaohua Wei ◽  
Yifeng Xia ◽  
...  

2020 ◽  
Vol 121 (05) ◽  
pp. 340-347
Author(s):  
A. B. Yildirim ◽  
D. Karabulut ◽  
E. Ozturk ◽  
E. Kaymak ◽  
B. Yalcin ◽  
...  

2019 ◽  
Vol 9 (1) ◽  
Author(s):  
Daniel Ryan ◽  
Jim Koziol ◽  
Wael M. ElShamy

AbstractDissemination of metastatic precursors from primaries is the primary reason for patient death. Dissemination encompasses tumor cells invasion of stroma, followed by intravasation through the endothelium barrier into the bloodstream. Here, we describe how geminin-overexpressing tumor cells acquire dissemination ability. Acetylated HMGB1 (Ac-HMGB1) secreted by geminin-overexpressing cells activates RAGE and CXCR4 expression on mesenchymal stem cells (MSCs) located in tumor stroma. Through secreting CXCL12, geminin-overexpressing cells recruit these CXCR4+-MSCs into the tumor. Within the tumor, MSCs differentiate into S100A4-secreting cancer-associated fibroblasts (CAFs). S100A4, in a reciprocal manner, activates geminin-overexpressing cells to secrete CCL2 that recruits M0-macrophages from the stroma into the tumor. Within the tumor, CCL2 polarizes M0-macrophages into Gas6-secreting M2-tumor-associated macrophages (M2-TAMs). In concert, geminin-overexpression, S100A4/RAGE and Gas6/AXL signaling promote the invasive and intravasation abilities in geminin-overexpressing cells through exacerbating their stemness and epithelial-to-mesenchymal phenotypes and enhancing expression and functional interaction of CD151 and α3β1-integrin in geminin-overexpressing cells. Tumors formed following injection of geminin-overexpressing cells admixed with MSCs/CAFs grew faster, metastasized earlier, especially to lungs, and were extremely sensitive to anti-c-Abl, anti-RAGE, and anti-AXL drugs. These data support an intrinsic ability in geminin-overexpressing tumor cells to promote their metastatic potential through recruitment and bi-directional interactions with MSCs/CAFs and M2-TAMs.


2019 ◽  
Vol 34 (Supplement_1) ◽  
Author(s):  
Bruna Bosquetti ◽  
Paulo Gregório ◽  
Regiane Cunha ◽  
Fellype Barreto ◽  
Andréa Stinghen
Keyword(s):  

Sign in / Sign up

Export Citation Format

Share Document